A Clinical Trial of the Safety and Anti-Tumor Activity of AB-201 in Subjects With Advanced HER2+ Solid Tumors
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc.
Orion Biotechnology Polska Sp. z o.o.
GC Cell Corporation
Erasmus Medical Center
Eastern Cooperative Oncology Group
Sorrento Therapeutics, Inc.
NKGen Biotech, Inc.
University of Southern California
Southwest Hospital, China
National Cancer Institute (NCI)
University of Alabama at Birmingham